Table 1. Comparison of changes in disease activity by cabergoline and placebo.
| Variable | Beforecabergoline | Aftercabergoline | P value | Beforeplacebo | Afterplacebo | P value |
| Morning stiffness (min) | 17.8±28.5 | 25.6±45.7 | 1.000 | 18.3±29.5 | 30.0±78.8 | 1.000 |
| Tender joint count | 6.7±3.6 | 2.7±2.3 | 0.011 | 3. 9±4.4 | 3.0±2.9 | 0.594 |
| Swollen joint count | 4.1±2.6 | 2.0±1.6 | 0.031 | 2.7±3.4 | 1.8±2.8 | 0.344 |
| Patient assessment of | 5. 6±3.5 | 3.2±2.4 | 0.047 | 4.9±3.4 | 4.1±3.6 | 0.438 |
| pain (vas) | ||||||
| Patient global assessment | 4.67±3.2 | 2.6±1.8 | 0.516 | 4.2±3.3 | 3.8±3.7 | 0.625 |
| of disease activity (vas) | ||||||
| ESR (mm/h) | 41.0±18.6 | 29.8±16.1 | 0.156 | 24.7±18.3 | 30.7±23.7 | 0.438 |